Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Topical Corticosteroid Recalled
11/24/2021
Jolynn Tumolo
A prescription corticosteroid used to treat eczema, dermatitis, and other skin conditions is under a Class II recall.
A prescription corticosteroid used to treat eczema, dermatitis, and other skin conditions is under a Class II recall.
A prescription corticosteroid...
11/24/2021
Pharmacy Learning Network
News
Hypertension Patches Recalled
11/24/2021
Jolynn Tumolo
The FDA issued a Class III recall for a prescription medication used to treat high blood pressure.
The FDA issued a Class III recall for a prescription medication used to treat high blood pressure.
The FDA issued a Class III...
11/24/2021
Pharmacy Learning Network
News
Class I, II Recalls for OTC Antifungal Sprays
11/24/2021
Jolynn Tumolo
Several lots of antifungal sprays have been voluntarily recalled due to the presence of benzene, a human carcinogen, in product samples.
Several lots of antifungal sprays have been voluntarily recalled due to the presence of benzene, a human carcinogen, in product samples.
Several lots of antifungal...
11/24/2021
Pharmacy Learning Network

Advertisement

News
Pain Reliever Recalled
11/18/2021
Jolynn Tumolo
A Class II recall has been issued for an over-the-counter pain medication marked for hospital use.
A Class II recall has been issued for an over-the-counter pain medication marked for hospital use.
A Class II recall has been...
11/18/2021
Pharmacy Learning Network
News
Antibiotic Recalled
11/18/2021
Jolynn Tumolo
A prescription antibiotic is under a Class II recall for failing to meet impurity/degradation specifications.
A prescription antibiotic is under a Class II recall for failing to meet impurity/degradation specifications.
A prescription antibiotic is...
11/18/2021
Pharmacy Learning Network
News
Vasodilator Tablets Recalled
11/18/2021
Jolynn Tumolo
A Class II recall has been issued for a prescription medication used to treat erectile dysfunction and benign prostatic hyperplasia.
A Class II recall has been issued for a prescription medication used to treat erectile dysfunction and benign prostatic hyperplasia.
A Class II recall has been...
11/18/2021
Pharmacy Learning Network

Advertisement

News
Class I Recall for Antibiotic Injection
11/11/2021
Jolynn Tumolo
A prescription antibiotic injection was placed under a class I recall after a customer found glass particles in a vial.
A prescription antibiotic injection was placed under a class I recall after a customer found glass particles in a vial.
A prescription antibiotic...
11/11/2021
Pharmacy Learning Network
News
Class I Recall for Mislabeled Muscle Relaxant
11/11/2021
Jolynn Tumolo
Methocarbamol tablets are under a class I recall due to a labeling error listing incorrect medication strength.
Methocarbamol tablets are under a class I recall due to a labeling error listing incorrect medication strength.
Methocarbamol tablets are under...
11/11/2021
Pharmacy Learning Network
News
Cholesterol Drug Recalled
11/11/2021
Jolynn Tumolo
A class II recall was issued for prescription tablets used to treat high cholesterol and triglyceride levels.
A class II recall was issued for prescription tablets used to treat high cholesterol and triglyceride levels.
A class II recall was issued for...
11/11/2021
Pharmacy Learning Network

Advertisement

News
Blood Pressure Drugs Recalled Over Impurity
11/11/2021
Jolynn Tumolo
The FDA issued a class II recall on a prescription antihypertensive medication used to treat high blood pressure and diabetic nephropathy.
The FDA issued a class II recall on a prescription antihypertensive medication used to treat high blood pressure and diabetic nephropathy.
The FDA issued a class II recall...
11/11/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use